Purdue acquires promising pain treatment http://www.drugstorenews.com/article/purdue-acquires-promising-pain-treatment?utm_term=DSN204731&utm_source=MagnetMail&utm_medium=subject&utm_term=DSN%20A.M.%20-%20Kroger%20appoints%204%20new%20EVPs%2C%20Diplomat%20shifts%20focus%20to%20specialty%20with%20compounding%20sale&utm_content=DSN-NLE-DSNam-09-11-15 STAMFORD, Conn. — Purdue Pharma this week announced that it had VM902A, acquired an allosteric selective tropmyosin receptor kinase A (TrkA) inhibitor, from VM Pharma. TrkA inhibitors are part of a growing class of pain management therapies. VM902A has been tested in Phase I clinical trials, and Purdue plans […]
Filed under: General Problems | 2 Comments »